Pharmacology - Kidney & Diuretics Flashcards
Kidney Function - 5
- Renal pelvis: Collects urine, which is excreted via the ureter to the urinary bladder & out of the body.
- Regulates body fluid volume & balance.
- Maintains ion balance (e.g. sodium, chloride) & pH.
- Excretes foreign substances, including waste products like urea.
- Secretes renin, which activates the renin-angiotensin-aldosterone system (RAAS) for BP regulation.
Ultrafiltration: Normal & Opposing forces
Blood is filtered from the Glomerular Capillaries into the Bowman’s Capsule
Driving force:
PGC - Glomerular Capillary hydrostatic pressure
πBS - oncotic pressure in the Bowman’s Space (negligible in normal kidney)
Opposing forces:
πGC - oncotic pressure of blood plasma
PBS - Pressure in the Bowman’s Space
Tubular reabsorption, secretion & excretion - 5
- Reabsorption or absorption: movement of solutes & water from tubular filtrate into interstitial fluid & plasma.
- Secretion: movement of solutes & water from plasma & interstitial fluid into tubular filtrate.
Reabsorption / absorption or secretion can be: - Transcellular (through epithelial cell & across luminal & the basolateral membrane)
- Paracellular (through tight junctions between epithelial cells)
- Excretion: extrusion of solutes & water in the tubular filtrate by the kidneys
Major sites for Tubular Sodium Reabsorption
- 4
- The Proximal Convoluted Tubule (PCT)
- The Thick Ascending Limb (TAL) of the loop of Henle
- The Distal Tubule (DT)
- The Collecting Tubule (CT)
& the Collecting Duct (CD)
Diuretics: Ranked by ability to produce natriuresis and diuresis:
- 5
- Loop Diuretics:
Act on Thick Ascending Limb (TAL) of Loop of Henle - Thiazides & Thiazide-like diuretics:
Act on Distal Tubule - Potassium Sparing Diuretics:
Act on: Collecting Tubule & Collecting Duct - Osmotic Diuretics
Act on: Proximal Convoluted Tubule & Thin Descending Limb of the loop of Henle - Carbonic Anhydrase Inhibitors:
Act on Proximal Convoluted Tubule
Tubular Sodium Reabsorption in the PCT - 9
On the Luminal membrane:
1. Na+/H+ exchanger (H+ secretion)
2. Na/H exchanger activity enhanced by Ang II via AT-1 receptors increasing Na+ reabsorption in the PCT
3. Na+-coupled co-transporters (X = glucose, amino acids)
4. Uses these mechanisms to enter PCT from Tubular lumen
On the Basolateral membrane:
5. Driving force is activity of the basolateral Na+-K+ ATPase (Creates Na+ [gradient] between the tubular lumen & interstitial space)
6. Renal K+ channels
7. Moves from PCT to Interstitial fluid
Tight Junctions: (gaps in Basolateral membrane)
8. Water permeable
9. Reabsorption of Ca2+, Mg2+, K+, Cl-
Tubular Sodium Reabsorption in the PCT: - 8
On the Luminal membrane:
1. Na+/H+ exchanger (H+ secretion) – maintains pH balance
2. Na+-coupled co-transporters (X = glucose, amino acids)
On basolateral membrane:
3. Na+-K+ ATPase on basal membrane pumps out sodium, & creates Sodium [gradient], drives reabsorption of ions, glucose, amino acids, & other substances.
4. Potassium is recycled via potassium channels.
5. Tight junctions (not very tight): allow Ca, Mg, K, Cl, & H20 to pass through.
6. Increased osmolarity in interstitial space by drugs can pull ions along, aiding in reabsorption
7. 99% of glucose reabsorbed via sodium-glucose transporters (important in diabetes treatment).
8. Drugs can interact with organic anion & cation transporters, influencing each other’s excretion pathways & potentially causing DI.
Carbonic Anhydrase Inhibitors: Acetazolamide - 6
- Inhibition of carbonic anhydrase in the PCT
- The enzyme reversibly converts carbonic acid into H2O & CO2 in the lumen, & CO2 &+ H2O to bicarbonate (HCO3-) & protons (H+) inside the epithelial cell.
- Protons excreted via luminal Na+/H+ exchanger on the proximal tubule
Renal effects of acetazolamide: - Moderate decrease in Na+ reabsorption
- Mild plasma acidosis (due to H+ retention)
- Urine alkalosis (due to increased bicarbonate secretion)
Carbonic Anhydrase Inhibitors: Acetazolamide: Uses -
Urine alkalisation
1. Reduces formation of uric acid & cystine stones
2. Increases excretion of weak acids (e.g. salicylates, barbiturates)
3. Decreases crystallisation of weak acids in the urine (e.g. anti-bacterial sulphonamides)
4. Altitude sickness (reduces respiratory plasma alkalosis by making plasma more acidic)
5. In glaucoma
Urine alkalisation: Drugs which can increase urine pH - 2
- Sodium bicarbonate (to treat aspirin overdose)
- Citrate (metabolised to bicarbonate increasing levels and its secretion)
Mechanism of diuretic action: e.g. Mannitol - 8
- Freely filtered in the glomerulus
- Pharmacologically inert and not reabsorbed
- Increases osmolarity of the tubular filtrate
- Decreases water reabsorption
- Increases sodium excretion (by retaining sodium ions in diluted filtrate – secondary effect)
- Act on areas freely permeable to water: PCT & Descending Limb of the loop of Henle
- Collecting tubule and Collecting duct in the presence of ADH
Osmotic Diuretics: Therapeutic applications. E.g. Mannitol - 5
- Weak diuretics, rarely used in the kidney
- May be used in acute renal failure
- Non-renal uses (increase osmolarity of blood plasma):
- Cerebral oedema (to reduce intracranial pressure)
- Glaucoma (to reduce intraocular pressure)
Effects of Loop Diuretics (e.g., Furosemide and Bumetanide) - 5
- Inhibit the NKCC2 cotransporter (Ion reabsorption), leading to:
- Reduced Na, Cl, Ca, & Mg (decreased reabsorption, secretion).
- Hypocalcaemia & hypomagnesemia in some patients due to disrupted absorption.
- Increased K excretion as K channels remain open.
- Diuretics reduce Na absorption, can result in low plasma Na levels, requiring supplementation.
Pharmacokinetics of Loop Diuretics (e.g. Furosemide, Bumetanide) - 4
- Absorbed in gut & secreted into filtrate by organic anionic transporters.
- Share these transporters with other drugs (e.g., uric acid), possible DIs affecting their excretion.
- Delivered to the site of action as filtrate flows to the Loop of Henle.
- Excreted in the urine
LOOP DIURETICS e.g. Furosemide, Bumetanide: Therapeutic uses
- 5
- Acute pulmonary oedema
- Diuretic resistant oedemas
- Resistant hypertension
- Patients with impaired kidney function or with CHF
- Liver cirrhosis with ascites